Partners' Directory

  Home   Search   Join the Partnership   Login

Contact General Specializations in Countries Contribution to the Global Plan Declaration

View this partner's profile

Organization Contact Information

Name: Abt Associates
Street 1: 4550 Montgomery Avnue
Street 2: Suite 800 North
City: Bethesda
Province: Maryland
Post Code: 20814-3343
Country: United States of America
Phone: +1-301-347-5000
Web Site:

Focal Point Contact Information

Salutation: Dr
First Name: John
Last Name: Osika
Title: Principal Associate
Phone: 301-347-5107

Alternate Focal Point Contact Information

Salutation: Dr.
First Name: John
Last Name: Osika
Title: Principal Associate

General Information

Board Constituency: Private sector
Organization Type - Primary: Private Sector
Organization Type - Secondary: Company
Is your organization legally registered in your country: Yes
Organization Reach: International
Organization Description:
Abt Associates is a mission-driven, global leader in research and program implementation in the fields of health, social and environmental policy, and international development. Known for its rigorous approach to solving complex challenges, Abt Associates was ranked as one of the top 20 global research firms in 2011 and also named one of the top 40 international development innovators. The company has multiple offices in the U.S. and program offices in nearly 40 countries.

Abt Associates has been actively engaged in fighting TB since the late 1990s and continues to fight TB in India, Nigeria, Ethiopia, Armenia, Azerbaijan and the countries of Central Asia, coordinating with local governments, U.S. government agencies, the Global Fund to Fight AIDS, Tuberculosis and Malaria, and other in-country local and international partners. Abt Associates works to strengthen government health systems, build strong linkages to key civil society organizations, and engage the private sector in expanding access to and delivery of quality TB services and support through innovation, collaboration and local capacity development.

Fostering Private Sector TB Partnerships in India
Recognizing the potential of the private sector in improving public health outcomes, USAID/India initiated the Market-based Partnerships for Health (MBPH) project, a four-year $12.5 million project that expanded on Abt’s innovative work in India under the USAID-funded Private Sector Partnerships-One (PSP-One) project (2004-2009). Through MBPH, Abt was successful in developing a robust, integrated public-private model for engaging private healthcare providers for TB care and support. Its effectiveness in among the vulnerable urban slum population in Karnataka, for example, has been demonstrated through a greater than 80% increase in sputum microscopy among TB suspects and a greater than 40% increase in TB detection. The project also developed extensive training modules and tools for all types of health-care providers, both private and public, which ha
Total number of staff in your organization: 100 +
Number of full-time staff who are directly involved with TB: 6 - 10
Number of part-time staff who are directly involved with TB: 0
Number of volunteers who are directly involved with TB: 0
What is your organization's annual budget (USD) dedicated to TB? Unable to disclose amount
How did you hear about the Stop TB Partnership: Involvement in TB control provision
If you were informed or referred by another partner of the Stop TB Partnership please tell us who:
Why do you wish join the Stop TB Partnership: Network with other partners
Are you a member of a Stop TB national partnership: No
Are you in contact with your national TB programme: No
Please tell us how your organization is contributing to your country's national TB control plan:
Abt's TB work falls under the International Health Division

Geographical Reach

Which country is your headquarters located in: United States of America
Which WHO region is the main focus of your work: Global
Which countries do you do operate in:
(This includes countries you are conducting activities in)
Burkina Faso
Cote d'Ivoire
Democratic Republic of the Congo
Dominican Republic
Sierra Leone
Viet Nam


Delivery of health services and care
Technical Assistance

Specializations in Countries

Technical Assistance Armenia
Technical Assistance Azerbaijan
Technical Assistance Ethiopia
Technical Assistance India
Technical Assistance Kazakhstan
Technical Assistance Kyrgyzstan
Technical Assistance Mozambique
Technical Assistance Turkmenistan


Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below:

TB Care Delivery:
Abt is currently implementing USAID/Ethiopia's Private Health Sector Program (PHSP), a 5-year, $21 million project that enables the Government of Ethiopia to partner effectively with private health providers to deliver critical public health services, including provision of national-standard TB DOTS and integrated TB-HIV services. While tuberculosis control efforts in Ethiopia have improved significantly in the past decade with the expansion of the TB DOTS, Ethiopia remains on the WHO lists of high burden TB, MDR-TB and HIV countries.
PHSP activities to support provision of TB services through private clinics have included:
• Clinical capacity building through training and ongoing supportive supervision;
• Improving TB microscopy services through facilitating External Quality Assessments in collaboration with the Federal Ministry of Health;
• Strengthening the supply chain for the TB with HCT services at all targeted private and workplace clinics in collaboration with local government health offices;
• Building business and financial management skills of clinic owners and managers.
Public-Private Mix for TB control (PPM-DOTS) began in Ethiopia as a pilot program in Addis Ababa and Oromia in 2006. By 2011, with Abt’s assistance, the number of PPM-DOTS facilities throughout the country increased to 295, and the contribution of PPM-DOTS to the national case detection of all-forms of TB rose from 1% in 2007 to 9.5% in 2011.

As a result of Abt-led activities, the scope of primary health care services in government health facilities throughout Central Asia was expanded to include DOTS-based TB care, and treatment and continuous facility-level quality improvement processes have been instituted. Thousands of health professionals have been trained on DOTS. And undergraduate medical education programs throughout the region now include TB in their curricula.

Drug-Resistant TB:
Four of the five countries included in Abt Associates’ anti-TB project in Central Asia – Kazakhstan, Kyrgyzstan, Tajikistan, and Uzbekistan – are on the World Health Organization’s global list of High Burden Multi-Drug-Resistant TB countries. Abt Associates has partnered with the national TB programs in each country, with regional TB programs, and with the U.S. Agency for International Development to:

• Conduct widespread training of health workers on DOTS, including interpersonal communications skills to improve patient adherence to treatment and reduce the risk of multidrug-resistant TB;
• Coordinate between civilian and prison TB services to identify and address barriers to early diagnosis and effective treatment of TB and multidrug-resistant TB, and to improve referral systems between the civilian and prison systems in a pilot district in Kyrgyzstan.

With USAID funding, Abt is developing Armenia’s first dedicated National MDR-TB Guidelines in cooperation with the NTP and other in-country TB stakeholders. The project has also supported development of two MDR working committees and has introduced a scoring system for choosing the patients for treatment from the MDR-TB waiting list.

Beginning in 2010, the USAID/Health Systems 20/20 project, implemented by Abt Associates, collaborated with the NTBLCP in Nigeria on developing improved TB supportive supervision systems. Between 2010 and 2012, the pilot project implemented four rounds of supportive supervision using the smartphones in the four pilot states. At the end of the pilot, Abia, Kano, and Lagos reported substantial improvements in major areas of TB care, including cure rates, TB/HIV co-infection treatment, and defaulter rates: In Lagos Mainland LGA, the proportion of TB/HIV co-infected patients on cotrimoxazole preventive treatment (CPT) jumped to 100% in March 2012 from 33% in March 2011; it was still at 100% as of the most recent supervision visit in May 2012. At the same time, the proportion of TB/HIV co-infected patients on ART increased from 54% to 68% between March 2011 and May 2012. There was also an improvement in the new smear-positive cure rate, increasing from 62% in March 2011 to 79% in May 2012. In Ikeja LGA, Lagos, the defaulter rate dropped from 20% in March 2011 to 5.2% in May 2012.

The NTBLCP is currently expanding this program and working with Abt on new technologies to improve TB health outcomes and reduce TB program costs.
The Clinical HIV/AIDS Services Strengthening Project in Sofala, Manica and Tete (CHASS-SMT) is a five-year cooperative agreement led by Abt Associates, in collaboration with subgrantee FHI360, that works to improve HIV clinical services in Sofala, Manica and Tete provinces of Mozambique within a strengthened comprehensive primary health care system. CHASS-SMT addresses TB/HIV co-infection by providing capacity building, mentoring and coordination at the district and health-facility levels; conducting needs assessments of X-ray services at the provincial level; supporting the integration of the HIV and TB services at the provincial and district levels; and supporting HIV/TB testing and screening campaigns at the provincial level.

New Diagnostics:
Abt is working on a low-cost internet-based system to rapidly send GeneXpert MDR-TB test results to a central cloud system and quickly deliver them to NTP action-takers. Currently being piloted in Nigeria in coordination with Dr. Joshua Obasanya of the National TB and Leprosy Control Programme, who believes this system will allow the National Tuberculosis and Leprosy Control Program to:
• Better identify MDR-TB cases through more coordinated and rapid responses to case finding;
• Increase the number of MDR-TB patients on early treatment, improving outcomes and reducing transmission rates;
• Improve strategic planning across all TB cases by tying results into existing
TB program management systems, including eTB Manager;
• Control costs through central monitoring of GeneXpert use and error reports.


Declaration of interests:
No known conflicts of interest to declare.

Application date: October 30, 2012
Last updated: April 19, 2017